Skip to main content

Table 3 Data collection schedule for the BETA Trial, Alberta, Canada

From: Study design and methods for the Breast Cancer and Exercise Trial in Alberta (BETA)

Assessments

Time (months)

−1 to 0 baseline*

6

12 end of study

24 follow-up

Early screening

    

Participant Eligibility Questionnaire

x

   

Questionnaires

    

Baseline Health

x

   

Past Year Total Physical Activity Questionnaire

x

 

x

x

Canadian Diet History Questionnaire

x

 

x

x

Quality of Life

x

 

x

x

Predictors of Exercise Adherence

x

 

x

x

Psychological Stress

x

 

x

x

Satisfaction with Life, Happiness

x

 

x

x

Sedentary Behavior (SIT-Q)

x

 

x

x

Pittsburgh Sleep Quality Index

x

 

x

x

Participant Satisfaction with Exercise Intervention

  

x

 

PAR Med-X 1

x

   

Objective measurements

    

Blood Sample

x

x

x

x

Submaximal Fitness Test

x

 

x

x

Anthropometry (height, weight, waist/hip circumference)

x

 

x

x

Accelerometry

x 2

x

x

x

CT Scan3

x

 

x

x

DXA Scan4

x

 

x

x

  1. *All baseline measurements and questionnaires were completed prior to randomization. The exercise intervention began at baseline (time 0).
  2. 1PAR Med-X: Physical Activity Readiness Medical Examination.
  3. 2Step count data were retrieved from the accelerometer devices to assess study eligibility for any participant with a VO2max determined to be between 34.6 and 37.0 mL/kg/min.
  4. 3CT Scan: Computed Tomography Scan.
  5. 4DXA Scan: Dual Energy X-Ray Absorptiometry Scan.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us